Ortin Laboratories Ltd Share Price & Stock Analysis

Ortin Laboratories Ltd (BSE: 539287) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹11 Cr, it ranks #4,742 by market cap among the 6,197 Indian listed companies on FinBizNet, and #79 of 86 in Medicinal Chemicals and Botanical Products. At ₹12.75 (as of 16 Nov 2026), the share price is 40.1% below its 52-week high of ₹21.30 and 15.9% above its 52-week low of ₹11.00. The share price is up 11.3% over one year and down 19.2% over three months.

Key Metrics

Current Price₹12.75
Market Cap₹11 Cr
BSE Code539287
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E RatioNot meaningful (loss)
Return on Equity-45.96%
Return on Assets-15.24%
52-Week Range₹11.00 – ₹21.30
1-Year Price Change+11.3%
3-Month Price Change-19.2%
Beta (1Y)-0.13
Dividend Yield0.00%
HeadquartersHyderabad, Telangana
Websitewww.ortinlabsindia.com

Latest Quarterly Results — Q2 FY27

Revenue₹0 Cr
Net Profit₹-0 Cr
Net Margin-900.0%
EPS (Basic)₹-0.33
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Ortin Laboratories Ltd Quarterly Revenue and Profit Trend

Ortin Laboratories Ltd reported revenue of ₹0 Cr in Q2 FY27, up 200.0% from ₹0 Cr in Q2 FY26 and up 200.0% from ₹0 Cr in Q1 FY27. It posted a net loss of ₹0 Cr for the quarter, against a net loss of ₹1 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹0 Cr (Q1 FY27) to ₹0 Cr (Q4 FY25). The company reported a net loss in 7 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹0 Cr−₹0 Cr−900.0%
Q1 FY27₹0 Cr−₹0 Cr−3400.0%
Q4 FY26₹0 Cr−₹0 Cr−33.3%
Q3 FY26₹0 Cr−₹0 Cr−500.0%
Q2 FY26₹0 Cr−₹1 Cr−5000.0%
Q1 FY26₹0 Cr−₹0 Cr−450.0%
Q4 FY25₹0 Cr−₹0 Cr−320.0%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 1.24% of Ortin Laboratories Ltd's shares as of Sept 2026, against 1.23% in Sept 2025 (+0.01 percentage points). Delivery averaged 79.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Ortin Laboratories Ltd

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemi

Products and Services

1. Manufacturing of Pharmaceutical Products-This segment engages in the manufacture and sale of drug intermediates and pharmaceutical products.

Ortin Laboratories Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Ortin Laboratories Ltd₹11 Crn/m-45.96%₹0 Cr+11.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ortin Laboratories Ltd?

Ortin Laboratories Ltd is trading at ₹12.75, with a market capitalisation of ₹11 Cr.

Which sector does Ortin Laboratories Ltd belong to?

Ortin Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Ortin Laboratories Ltd?

Ortin Laboratories Ltd has a return on equity of -45.96%.

What is the stock symbol of Ortin Laboratories Ltd?

Ortin Laboratories Ltd is listed on the BSE under the scrip code 539287.

How has Ortin Laboratories Ltd's share price moved over the past year?

Ortin Laboratories Ltd's share price is up 11.3% over one year and down 19.2% over three months. Its 52-week range is ₹11.00 to ₹21.30.

What were Ortin Laboratories Ltd's latest quarterly results?

In Q2 FY27, Ortin Laboratories Ltd reported revenue of ₹0 Cr and net profit of ₹-0 Cr, with basic EPS of ₹-0.33 (standalone, parsed from the company's exchange filing).

How have Ortin Laboratories Ltd's revenue and profit changed over the past year?

Ortin Laboratories Ltd reported revenue of ₹0 Cr in Q2 FY27, up 200.0% from ₹0 Cr in Q2 FY26 and up 200.0% from ₹0 Cr in Q1 FY27.

What is the promoter holding in Ortin Laboratories Ltd?

Promoters held 1.24% of Ortin Laboratories Ltd's shares as of Sept 2026, against 1.23% in Sept 2025 (+0.01 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.